Serum tumor necrosis factor and interleukin 1 in leprosy and during lepra reactions

Tumor necrosis factor—α (TNF), one of the mediators of septic shock, has a role in the immunopathological complications of several infections. However, its role in leprosy is yet unclear. In this study, serum TNF and IL-1 levels in 64 patients spread over the spectrum of leprosy [lepromatous leprosy (LL), 30; borderline lepromatous, 12; borderline borderline, 8; and borderline tuberculoid-tuberculoid leprosy, 14] were measured at the time of admission. Elevated levels of TNF ranging from 15 to 4500 pg/ml were detected in lepromatous leprosy cases (399 ± 189) and low levels ranging from 15 to 160 pg/ml were detected in the tuberculoid form of leprosy. Patients undergoing type 1 and type 2 lepra reactions also exhibited high TNF levels of 15–2100 pg/ml. Of the 14 clinically healthy individuals studied, 3 showed TNF levels of 15, 50, and 58 pg/ml. Interleukin 1-β (IL-1) levels were found to be significantly higher in LL cases (70–5000 pg/ml) (328 ± 184) in comparison to other groups or normal controls (9 ± 3). The coefficient of correlation between TNF and IL-1 levels was statistically significant in LL and reaction cases ( r = 0.96, P < 0.001). These patients were followed up as outpatients for a period of 1 year. It was observed that 4 out of 8 patients with TNF levels >100 pg/ml went into lepra reactions between 2 and 6 months after entry into the study, whereas only 5 out of 56 with